Profile avatar
osmind.bsky.social
The premier technology platform for breakthrough mental health treatment and research. Learn more at Osmind.org
81 posts 320 followers 139 following
Regular Contributor
Active Commenter
Posts 11 Comments 39

New Date: March 5th at 2pm PST / 5pm EST Join us to explore your options in private practice, from two entrepreneurial clinicians who went beyond the standard path!

submitted 3 days ago • 0 comments

🎙️ NEW PSYCHIATRY TOMORROW EPISODE: From Crisis to Community with Matthew Bernstein MD "Getting people connected to real jobs, school, relationships—these experiences can reduce symptoms and take the place of medications in many respects."

submitted 8 days ago • 1 comment

Psychiatrists and Psych NPs: Traditional private practice isn't your only path to independence. From private equity partnerships to specialized interventional centers to national treatment networks, you have more options than ever.

submitted 9 days ago • 1 comment

Want to explore your options beyond traditional private practice? Here's what you'll learn in our free fireside chat with two psychiatrists who've built successful practices through different paths:

submitted 15 days ago • 1 comment

The FDA's March 2024 approval of TMS for adolescent depression (ages 15-21) gives clinicians a powerful new tool in our therapeutic arsenal. With only two FDA-approved medications for this age group and rising post-pandemic depression rates, this clearance couldn't come at a more critical time.

submitted 16 days ago • 1 comment

New research: Ketamine therapy shows promise for treatment-resistant PTSD with comorbid depression 🧠

submitted 24 days ago • 1 comment

We had a fantastic time at the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) Annual Conference, sharing how real-world evidence can transform ketamine therapy and advance psychiatric care. So great connecting with familiar and new faces!

submitted 30 days ago • 0 comments

Last chance to register - happening tomorrow!

submitted 32 days ago • 0 comments

10 years ago, a psychiatrist stood before Kaiser Permanente's committee with an unconventional proposal: bringing ketamine therapy to one of America's largest health systems. "You have to understand how incredible this was," recalls Dr. L. Alison McInnes MD, MS,VP of Scientific Affairs at Osmind.

submitted 35 days ago • 1 comment

Want to learn about using TMS to treat depression in adolescents? Here's what you'll learn in our free January 28th webinar:

submitted 37 days ago • 1 comment

"We need guidelines." "Where are the standards?" "How do we ensure safety?" These are the questions we've heard from clinicians about ketamine therapy. Now, there's an answer...

submitted 38 days ago • 1 comment